The CSL share price is up 25% in 12 months

The CSL Limited (ASX:CSL) share price is up 25% in 12 months. Is it too late to invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday the CSL Limited (ASX: CSL) share price dropped 1% lower to finish the day at $1.99.

Despite this small decline, the biotherapeutics company's shares are up an impressive 25% over the last 12 months.

Why is the CSL share price up 25% in 12 months?

The CSL share price has been on fire over the last 12 months thanks to an impressive performance in FY 2018 and an equally positive start to FY 2019.

The company posted a net profit after tax of US$1,729 million in FY 2018, which was up by 29% on the prior corresponding period. This was driven by strong sales of its Privigen, Hizentra, and IDELVION products and supported by the launch of the HAEGARDA product.

The good news for shareholders is that the positive momentum has carried over into FY 2019 with the company releasing a solid half year result in February.

CSL posted a 9% increase in total half year revenue to US$4.5 billion and a 7% (10% in constant currency) increase in net profit after tax to US$1.2 billion.

The strong top line growth was the result of an 8% lift in revenue by its CSL Behring business and a 21% jump in revenue by its fledgling Seqirus influenza business.

Pleasingly, management also provided guidance which indicates that the second half will be even stronger.

It advised that the company is trending towards the upper end of its full year profit guidance range of US$1,880 million to US$1,950 million, which will mean year on year growth of approximately 13%.

Is it too late to invest?

Although its shares are not cheap at 33x estimated forward earnings, I think the quality of the business and its strong long term growth potential makes it deserving of this premium.

As a result, despite its strong share price rally over the 12 months, I would still class CSL as a buy along with fellow healthcare shares Cochlear Limited (ASX: COH) and ResMed Inc. (ASX: COH).

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Happy teen friends jumping in front of a wall.
Share Gainers

Guess which 4 ASX 200 shares are rocking new 52-week highs today!

Investors just sent these four ASX 200 shares to one-year-plus highs.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Evolution Mining, Orthocell, Platinum, and Turaco shares are charging higher

These shares are having a better day that most on Thursday.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing hump day session for the ASX today.

Read more »

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX managed to bank a small rise this Tuesday.

Read more »

Sport trainer talking to little girl who is climbing wooden ladder in gym.
Share Gainers

Why Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today

These shares are gaining on Tuesday, but why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Financial Shares

5 best ASX 200 financial shares of FY25 (CBA didn't make the cut!)

These stocks were well and truly 'in the black' for share price growth last financial year.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Amaero, Black Cat, Domino's, and Ramelius shares are racing higher today

These shares are having a good session on Tuesday. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week for investors this Monday.

Read more »